Inventory / revenue moved 26196 bp higher
Inventory / revenue changed +26196 basis points from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Inventory / revenue changed +26196 basis points from the comparable as-filed period.
SBC / revenue changed +245783 basis points from the comparable as-filed period.
Stock-based compensation changed -22.9% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Current liabilities changed -21.0% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Cash & equivalents changed +9.2% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Selling, general & administrative changed -6.9% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Free-cash-flow margin changed -2039545 basis points from the comparable as-filed period.
Operating cash-flow margin changed -2011089 basis points from the comparable as-filed period.
R&D / revenue changed +1719522 basis points from the comparable as-filed period.
Shares outstanding changed +11.4% from the comparable as-filed period. The change ranks at the 33th percentile of 6 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.